How Do Different Laser Wavelengths And Mediums Function In Ablative Fractional Laser Devices? Understand Key Differences For Optimal Skin Resurfacing

Laser wavelength determines what the tissue absorbs, while the laser medium determines how that wavelength is generated. In ablative fractional devices, water-absorbed wavelengths create microscopic columns of vaporized tissue, often surrounded by thermal coagulation. CO₂ at 10,600 nm produces deeper ablation and remodeling, Er:YAG at 2,940 nm produces cleaner, more superficial ablation, and hybrid systems combine ablative and non-ablative wavelengths to treat different tissue layers.

The practical distinction is simple: the wavelength controls tissue effect, while the gain medium—such as CO₂ gas, Er:YAG crystal, or Nd:YAG crystal—creates that wavelength. Fractional delivery limits treatment to microscopic columns, balancing clinical effect with faster healing than full-field resurfacing.

How Fractional Ablation Works

Microscopic treatment columns

A fractional handpiece divides the beam into an array of microbeams rather than treating the entire surface continuously. Each beam creates a microscopic treatment zone, leaving untreated skin between the columns.

These untreated areas support re-epithelialization and repair. The result is generally faster recovery than fully ablative resurfacing, although the depth and density of treatment still strongly affect downtime.

Ablation and coagulation are different effects

Ablation is the removal or vaporization of tissue. It occurs when absorbed laser energy rapidly heats intracellular water beyond the point at which tissue can remain intact.

Coagulation is thermal injury without immediate vaporization. It denatures tissue and stimulates remodeling, but it does not remove the same volume of tissue as ablation.

Many ablative fractional lasers produce both effects: a central vaporized column surrounded by a narrower zone of thermally coagulated tissue.

Why Wavelength Changes the Treatment Result

Water absorption controls penetration

Skin contains substantial amounts of water, so wavelengths with strong water absorption deposit energy close to the surface. The stronger the absorption, the more rapidly energy is confined to superficial tissue.

This affects ablation depth, residual thermal damage, precision, hemostasis, healing time, and the intensity of collagen remodeling.

Longer and shorter does not mean simply deeper or safer

Wavelength alone does not determine clinical depth. Pulse duration, energy per microbeam, spot size, treatment density, and the number of passes also influence the final tissue response.

A wavelength with strong water absorption may produce very precise superficial ablation, while a less strongly absorbed wavelength may distribute heat more broadly and create a larger coagulation zone.

The Main Ablative Wavelengths

CO₂ fractional lasers: 10,600 nm

The CO₂ laser uses a gas-based laser medium and emits at 10,600 nm, a wavelength strongly absorbed by water.

Its microbeams vaporize tissue and create a relatively substantial surrounding zone of thermal coagulation. This combination supports deeper resurfacing, collagen remodeling, and treatment of pronounced photodamage or more severe scar irregularities.

CO₂ systems are therefore associated with greater tissue effect and longer recovery than more superficial ablative approaches when comparable treatment density and energy are used.

Er:YAG fractional lasers: 2,940 nm

The Er:YAG laser uses an erbium-doped solid-state crystal and emits at 2,940 nm.

This wavelength has extremely high absorption in water, allowing energy to be deposited very precisely at the tissue surface. It produces efficient ablation with comparatively limited residual thermal damage.

The typical advantages are superficial precision, rapid re-epithelialization, and potentially less prolonged post-treatment inflammation. However, reduced thermal injury can also mean less coagulative remodeling and less hemostatic effect than a strongly thermal CO₂ treatment.

Er,Cr:YSGG fractional lasers: approximately 2,790 nm

YSGG systems generally refer to an erbium, chromium-doped yttrium-scandium-gallium-garnet crystal, commonly emitting at approximately 2,790 nm.

Its water absorption profile lies between the commonly described CO₂ and Er:YAG approaches. It can provide a balance of tissue vaporization and thermal coagulation.

The actual clinical result still depends heavily on pulse settings, energy, scanning pattern, and treatment density. The wavelength establishes the interaction profile, but the device settings determine how aggressively that profile is expressed.

Hybrid and Dual-Wavelength Systems

Erbium hybrid systems: 1,470 nm and 2,940 nm

Some hybrid platforms combine a 1,470 nm wavelength with 2,940 nm Er:YAG ablation.

The 2,940 nm component performs precise ablative resurfacing. The 1,470 nm component is more strongly used for controlled non-ablative heating and coagulation rather than tissue vaporization.

This pairing allows a clinician to combine surface renewal with deeper thermal stimulation. It can be useful when the treatment goal requires both epidermal ablation and dermal heating without relying on a single wavelength to perform both tasks.

Nd:YAG and Er:YAG combinations

Dual systems may combine a deeper-acting Nd:YAG wavelength with superficial Er:YAG ablation.

The Nd:YAG component is used for deeper thermal collagen stimulation, while Er:YAG provides controlled surface resurfacing. This creates a multi-layer treatment strategy rather than a purely ablative one.

The value of the combination is flexibility: the operator can adjust the relative contribution of deep heating and superficial ablation according to the indication, skin characteristics, and acceptable recovery period.

Where 1,440–1,927 nm wavelengths fit

Wavelengths in the approximate 1,440–1,927 nm range are commonly used for non-ablative fractional treatment. They primarily create microscopic zones of coagulation without removing tissue.

These wavelengths can be selected when the objective is dermal remodeling with less tissue loss and generally less downtime. They should not be described as equivalent to ablative wavelengths such as 2,790 nm, 2,940 nm, or 10,600 nm.

What “Medium” Means in a Laser Device

The gain medium generates the wavelength

The laser medium, also called the gain medium, is the material whose excited atoms or molecules generate laser light.

In the systems discussed here:

CO₂ lasers use a gas mixture as the gain medium and generate 10,600 nm light.
Er:YAG lasers use an erbium-doped yttrium-aluminum-garnet crystal and generate 2,940 nm light.
Er,Cr:YSGG lasers use a doped YSGG crystal and generate approximately 2,790 nm light.
Nd:YAG lasers use a neodymium-doped YAG crystal to generate a deeper-penetrating wavelength, commonly used for thermal stimulation.

The medium is therefore an engineering component, whereas the wavelength is the clinically important optical characteristic governing tissue absorption.

The tissue is the interaction medium

The skin itself is the medium through which the laser energy is absorbed, scattered, and converted into heat.

Water is the dominant absorber for the principal ablative wavelengths in this discussion. The amount and distribution of water in the epidermis and dermis largely explain why these wavelengths can vaporize or heat tissue.

How the Wavelength Affects Clinical Selection

Deeper remodeling

CO₂ fractional devices are generally suited to situations where a stronger ablative and thermal response is desired, such as substantial photodamage or more pronounced scar remodeling.

Their greater thermal component may provide stronger remodeling, but it usually requires more careful recovery management.

Precise superficial resurfacing

Er:YAG is appropriate when precise tissue removal and limited residual thermal injury are priorities.

It may be favored when rapid surface healing and controlled superficial ablation are more important than maximizing deep coagulation.

Combined surface and dermal treatment

Hybrid or dual-wavelength systems are useful when the treatment plan requires different effects at different depths.

Ablation can address surface texture and irregularity, while a non-ablative or deeper thermal wavelength can target dermal remodeling.

Skin phototype and recovery tolerance

Treatment selection must account for skin phototype, history of pigmentary change, the indication being treated, and the patient’s willingness to accept downtime.

A wavelength is not inherently “best” for every patient. The appropriate choice is the one that provides the required tissue effect with an acceptable risk and recovery profile.

Understanding the Trade-offs

More ablation is not automatically better

Increasing energy or treatment density can increase resurfacing intensity, but it also increases inflammation, recovery time, and the risk of complications.

Clinical benefit depends on matching treatment intensity to the problem rather than selecting the most powerful wavelength available.

Less thermal damage has both benefits and limitations

Er:YAG’s limited residual thermal injury can support faster healing and precise ablation.

However, less coagulation may provide less hemostasis and less immediate thermal remodeling than a CO₂ treatment, depending on the settings and treatment objective.

Fractional does not mean risk-free

Fractional treatment leaves untreated bridges of skin, but each microcolumn is still a controlled injury.

Post-treatment erythema, edema, pigmentary alteration, infection, delayed healing, and scarring remain possible, particularly when treatment is too aggressive or patient-specific risk factors are overlooked.

Device labels can oversimplify performance

Two devices using the same nominal wavelength may produce different results because of differences in pulse duration, beam profile, scanner design, spot size, energy control, and treatment density.

Comparing wavelength alone is therefore insufficient when evaluating equipment or predicting clinical outcomes.

Ablative and non-ablative terms must remain distinct

A wavelength that primarily creates coagulation should not be presented as equivalent to one that vaporizes tissue.

Hybrid systems can combine both effects, but the clinician must understand which component is ablating, which is heating, and how their settings interact.

How to Apply This to Your Project

The wavelength should be selected according to the desired tissue response, not simply the device name or marketing category.

If your primary focus is deep resurfacing and pronounced scar or photodamage remodeling: Consider a CO₂ fractional platform, recognizing its stronger thermal effect and typically greater recovery demands.
If your primary focus is precise superficial ablation with limited residual thermal injury: Consider an Er:YAG fractional platform at 2,940 nm.
If your primary focus is a balance between vaporization and coagulation: Evaluate an Er,Cr:YSGG system at approximately 2,790 nm and compare its actual pulse and scanning parameters.
If your primary focus is combining surface renewal with deeper heating: Consider a hybrid or dual-wavelength platform, such as 2,940 nm with 1,470 nm or a deeper Nd:YAG component.
If your primary focus is remodeling with minimal tissue removal and reduced downtime: Examine non-ablative fractional wavelengths in the approximate 1,440–1,927 nm range rather than assuming an ablative device is necessary.
If your primary focus is equipment comparison: Assess the gain medium, wavelength, pulse characteristics, maximum energy, fractional scanner, cooling, service support, and clinical indications together.

The right ablative fractional laser is the one whose wavelength, thermal profile, and delivery parameters match the required tissue effect and the patient’s recovery tolerance.

Summary Table:

Wavelength	Laser Medium	Ablation Depth	Thermal Coagulation	Ideal Use Case
10,600 nm (CO₂)	CO₂ gas	Deeper	Higher	Deep resurfacing, scar remodeling
2,940 nm (Er:YAG)	Er:YAG crystal	Superficial	Lower	Precise ablation, faster healing
2,790 nm (Er,Cr:YSGG)	Er,Cr:YSGG crystal	Moderate	Moderate	Balanced vaporization and coagulation
1,470 nm + 2,940 nm (Hybrid)	Er:YAG + diode	Superficial + deeper heating	Controlled	Combining surface renewal with dermal heating
1,440–1,927 nm (Non-ablative)	Various solid-state	None	Deep	Dermal remodeling with minimal downtime

Looking to expand your clinic's offerings with advanced fractional laser technology? BELIS provides state-of-the-art CO2, Er:YAG, and hybrid systems designed for professional use in clinics and premium salons. Our devices combine clinical efficacy with safety and reliability. Contact us today to discover how our lasers can elevate your practice and deliver exceptional results for your patients.